Amplitude Vascular Systems Secures $36M Series B Financing for IDE Trials

AVS raises $36M to support Pulse Intravascular Lithotripsy™ (PIVL™) device IDE trials and U.S. peripheral commercial launch.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here